Press Releases from Antibody Drug Conjugates Market (5 total)
Antibody Drug Conjugates Market To Witness Huge Growth By 2030
The Market Statsville Group (MSG) publishes the new report on the "Antibody Drug Conjugates Market by Product Type (Adcetris, Kadcyla, and Other Product Type), by Technology (Cleavable Linker and Non-Cleavable Linker), by Target Type (CD30 Antibodies, HER2 Antibodies, and Other Target Types), by Application (Breast Cancer, Cancer, Lung Cancer, Skin Cancer, Blood Cancer, Brain Tumor, and Other Applications), by End-Users (Hospitals and Speciality Cancer Centers, and Other End Users), by…
Antibody Drug Conjugates Market annual growth rate (CAGR) of 25.5% from 2016 to …
The global market for antibody drug conjugates was valued at $1.3 billion in 2016. The market should reach $4.2 billion by 2021, growing at a compound annual growth rate (CAGR) of 25.5% from 2016 to 2021.
Report Scope:
Antibody drug conjugates are mainly used to treat cancer and are safer and more effective than many other cancer therapies. This report focuses on the global market for antibody drug conjugate products and…
Development Trends: Global Antibody Drug Conjugates Market Demand and Opportunit …
ResearchMoz include new market research report "Antibody Drug Conjugates: Technologies and Global Markets" to its huge collection of research reports.
Antibody drug conjugate (ADC) technology is a relatively new technology and is continuously evolving due to various factors such as technological advances, recognition of appropriate target antigens, success of monoclonal antibodies (mAbs) and increasing demand for biologics/biotherapeutics. Advances in targeting antibodies, potent payloads and drug-linker technologies that facilitate improved ADC stability,…
At A Significant CAGR Of 25.5%, Global Market For Antibody Drug Conjugates Shoul …
Researchmoz added latest report "Antibody Drug Conjugates: Technologies and Global Markets". The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.
The global market for antibody drug conjugates was valued at $1.3 billion in 2016. The market should reach $4.2 billion by 2021, growing at a compound annual growth rate (CAGR) of 25.5% from 2016 to 2021.
Get a Sample PDF…
Antibody Drug Conjugates Market — Global Industry Insights, Trends, Outlook, a …
Antibody drug conjugate is a significant class of highly potent bio drugs envisioned as a broad therapy for treatment of cancer. Unlike chemotherapy, antibody drug conjugate are proposed to mark and kill only cancer cells. Antibody drug conjugates are compound molecules that comprise antibodies linked to a biologically active cytotoxic drug.
By uniting the exclusive targeting capacities of mAB with anti-cancer drugs, ADCs allow for subtle judgment between healthy…
